- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Immunological Tolerance in Norway
Total 66 results
-
Gilead SciencesCompletedHIV | Human Immunodeficiency Virus | HIV-1United States, Puerto Rico
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency Virus IUnited States, Canada, Puerto Rico
-
Gilead SciencesCompletedHIV InfectionCanada, Germany, United States, Spain, France, Australia, Puerto Rico, Italy, Belgium, Mexico, Switzerland, Portugal, Netherlands, United Kingdom
-
GlaxoSmithKlineCompleted
-
Bristol-Myers SquibbNo longer availableHIV InfectionsUnited States, Puerto Rico
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Denmark, France, Germany, Greece, Italy, Mexico, Netherlands, Portugal, Spain, Switzerland, United Kingdom
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusSpain, France, Germany, United States, Italy, Romania, Russian Federation, Switzerland, Puerto Rico
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, France, Canada, Portugal, Italy, Belgium
-
Tibotec Pharmaceuticals, IrelandApproved for marketingHIV InfectionsUnited States, Belgium, Germany, Taiwan, Spain, Switzerland, Mexico, Slovenia, Malaysia, Turkey, Canada, Netherlands, Denmark, Greece, Sweden, Russian Federation, Czech Republic, Puerto Rico, Thailand, Hungary, Luxembourg, Venezuela
-
ViiV HealthcareGlaxoSmithKline; PPDCompletedInfection, Human Immunodeficiency VirusUnited States, Canada, Puerto Rico
-
University of MinnesotaNational Health and Medical Research Council, Australia; Bristol-Myers Squibb; National Institutes of Health Clinical Center (CC) and other collaboratorsCompletedHIV InfectionSpain, United States, United Kingdom, Ireland, Australia, Argentina, Denmark, Sweden, Israel, Switzerland, Germany, Brazil, Norway, Chile, Thailand, Peru, Portugal, Greece, Luxembourg, Uganda, Austria, Belgium, Czechia, Estonia, Finland, ... and more
-
ViiV HealthcareTerminatedHIV-1 Infection | Infection, Human Immunodeficiency Virus IUnited States, France, Germany, Canada, Italy, Australia, Belgium, Portugal, Puerto Rico, Romania, United Kingdom
-
ViiV HealthcarePfizerCompletedHuman Immunodeficiency VirusUnited States, Canada, Spain, Belgium, France, United Kingdom, Italy, Brazil, Puerto Rico, Germany, Greece
-
Boehringer IngelheimApproved for marketingHIV InfectionsUnited States, Australia, Belgium, Denmark, France, Greece, Ireland, Italy, Portugal, South Africa, Switzerland, United Kingdom
-
BioCryst PharmaceuticalsCompletedHereditary Angioedema | Prophylaxis | HAEAustria, Denmark, France, Germany, Hungary, Israel, Italy, North Macedonia, Poland, Switzerland, United Kingdom, United States, Australia, Hong Kong, Korea, Republic of, New Zealand, Serbia, Slovakia, South Africa, Spain
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, France, Netherlands, Spain, Taiwan, Australia, Belgium, Russian Federation, Canada, United Kingdom, Mexico, Italy, South Africa, Romania, Argentina, Hungary, Poland, Chile, Greece, Brazil